학술논문

Phase I Dose Escalation Trial Of The DLL3/CD3 Igg-Like T Cell Engager BI 764532 In Patients with DLL3+Tumors: Focus on SCLC
Document Type
Journal
Source
JOURNAL OF THORACIC ONCOLOGY; NOV 2023, 18 11, pS45-pS46, 2p. Supplement: S
Subject
Language
English
ISSN
15561380